Fred Kurata
Los Angeles, CANPI 1205906740
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Glaukos Corporation at 50.5% of the total. Reporting peaked in 2019 at $1,220 and has fallen 88.5% since, to $141 in 2025.
Across 53 payments — averaging $46.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$1K
- Johnson & Johnson Surgical Vision, Inc.$438
- Ivantis, Inc$211
- Alcon$209
- Novartis$86
- Sight Sciences, Inc.$79
- plus $196 from 5 others
Across 3 payments — averaging $134,583 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch Health US, LLC$404K
What the payments were for
- Food & beverage$2,464100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 19 | $1,245 |
| Johnson & Johnson Surgical Vision, Inc. | 12 | $438 |
| Ivantis, Inc | 3 | $211 |
| Alcon | 7 | $209 |
| Novartis | 1 | $86 |
| Sight Sciences, Inc. | 2 | $79 |
| Beaver-visitec International, Inc. | 1 | $71 |
| Aerie Pharmaceuticals, Inc. | 4 | $66 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $34 |
| AbbVie | 1 | $14 |
| Akorn, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iStent inject Trabecular Micro-Bypass Stent System$332
- iStent inject W$141
- KXL System$141
- Photrexa$141
- iDoseTR$141
- Hydrus$124
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.